Structure Therapeutics Inc.
GPCR
$21.76
$3.2317.43%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 2.54% | 17.50% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.67% | 37.58% | |||
| Operating Income | -2.67% | -37.58% | |||
| Income Before Tax | -7.25% | -30.42% | |||
| Income Tax Expenses | 47.83% | 73.58% | |||
| Earnings from Continuing Operations | -7.36% | -30.51% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -7.36% | -30.51% | |||
| EBIT | -2.67% | -37.58% | |||
| EBITDA | -2.71% | -37.71% | |||
| EPS Basic | -7.22% | -12.72% | |||
| Normalized Basic EPS | 29.55% | -12.66% | |||
| EPS Diluted | -7.22% | -12.72% | |||
| Normalized Diluted EPS | 29.55% | -12.66% | |||
| Average Basic Shares Outstanding | 0.13% | 15.78% | |||
| Average Diluted Shares Outstanding | 0.13% | 15.78% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||